Pregnancy outcome of confined placental mosaicism: meta-analysis of cohort studies

Published:August 04, 2022DOI:


      This study aimed to assess the rate of adverse obstetrical and neonatal outcomes in pregnancies diagnosed with confined placental mosaicism relative to that of unaffected controls.

      Data Sources

      Web-based databases were searched using relevant key words, and articles published from 1980 to February 2022 were retrieved.

      Study Eligibility Criteria

      Observational studies in English language including ≥10 cases of singleton pregnancies with diagnosis of confined placental mosaicism were included. The diagnosis was established after detection of any chromosomal abnormality at chorionic villus sampling for any indication, followed by normal karyotype from amniotic fluid or neonatal leukocyte culture.


      Two authors independently screened the references for eligibility, data extraction, and assessment of methodological quality using the Newcastle–Ottawa scale. All available obstetrical and neonatal outcomes were recorded. Random-effect meta-analysis was performed to estimate pooled odds ratios and 95% confidence intervals of available outcomes in pregnancies with and without confined placental mosaicism. Statistical heterogeneity was evaluated with I2 statistics (International Prospective Register of Systematic Reviews registration number: CRD42021260319).


      Of the 80 articles reviewed, 8 retrospective matched-cohort studies (708 cases of confined placental mosaicism and 11,599 unaffected controls) compared cases with and without confined placental mosaicism and were included in the meta-analysis.
      The risk of delivering small-for-gestational-age neonates was significantly increased in confined placental mosaicism pregnancies according to crude analysis (odds ratio, 2.45; 95% confidence interval, 1.23–4.89; I2=72%) and to sensitivity analysis of high-quality studies (odds ratio, 3.65; 95% confidence interval, 2.43–5.57; I2=0%). Similarly, confined placental mosaicism resulted in an increased risk of birthweight below the third centile (odds ratio, 5.33; 95% confidence interval, 1.19–24.19; I2= 83%). Subgroup analysis revealed that the risk of delivering small-for-gestational-age neonates was 3-fold higher for confined placental mosaicism excluding trisomy 16, and 11-fold higher for cases including trisomy 16 only vs unaffected controls, respectively. No difference was found in the risk of low birthweight and preterm birth (at <37 weeks’ gestation). Other outcomes were insufficiently reported, therefore they were not analyzed.


      Pregnant women prenatally diagnosed with confined placental mosaicism have an increased risk of impaired fetal growth, suggesting the need for intensified antenatal surveillance.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Kalousek D.K.
        • Dill F.J.
        Chromosomal mosaicism confined to the placenta in human conceptions.
        Science. 1983; 221: 665-667
        • Simoni G.
        • Sirchia S.M.
        Confined placental mosaicism.
        Prenat Diagn. 1994; 14: 1185-1189
        • Grati F.R.
        Chromosomal mosaicism in human feto-placental development: implications for prenatal diagnosis.
        J Clin Med. 2014; 3: 809-837
        • Grati F.R.
        • Malvestiti F.
        • Branca L.
        • et al.
        Chromosomal mosaicism in the fetoplacental unit best practice & research.
        Clin Obstet Gynaecol. 2017; 42: 39-52
        • Battaglia P.
        • Baroncini A.
        • Mattarozzi A.
        • et al.
        Cytogenetic follow-up of chromosomal mosaicism detected in first-trimester prenatal diagnosis.
        Prenat Diagn. 2014; 34: 739-747
        • Wilkins-Haug L.
        • Quade B.
        • Morton C.C.
        Confined placental mosaicism as a risk factor among newborns with fetal growth restriction.
        Prenat Diagn. 2006; 26: 428-432
        • Stipoljev F.
        • Latin V.
        • Kos M.
        • Miskovic B.
        • Kurjak A.
        Correlation of confined placental mosaicism with fetal intrauterine growth retardation. A case control study of placentas at delivery.
        Fetal Diagn Ther. 2001; 16: 4-9
        • Kalousek D.K.
        • Howard-Peebles P.N.
        • Olson S.B.
        • et al.
        Confirmation of CVS mosaicism in term placentae and high frequency of intrauterine growth retardation association with confined placental mosaicism.
        Prenat Diagn. 1991; 11: 743-750
        • Mardy A.
        • Wapner R.J.
        Confined placental mosaicism and its impact on confirmation of NIPT results.
        Am J Med Genet C Semin Med Genet. 2016; 172: 118-122
        • Brison N.
        • Neofytou M.
        • Dehaspe L.
        • et al.
        Predicting fetoplacental chromosomal mosaicism during non-invasive prenatal testing.
        Prenat Diagn. 2018; 38: 258-266
        • Malvestiti F.
        • Agrati C.
        • Grimi B.
        • et al.
        Interpreting mosaicism in chorionic villi: results of a monocentric series of 1001 mosaics in chorionic villi with follow-up amniocentesis.
        Prenat Diagn. 2015; 35: 1117-1127
        • Hahnemann J.M.
        • Vejerslev L.O.
        European collaborative research on mosaicism in CVS (EUCROMIC)--fetal and extrafetal cell lineages in 192 gestations with CVS mosaicism involving single autosomal trisomy.
        Am J Med Genet. 1997; 70: 179-187
        • Ledbetter D.H.
        • Zachary J.M.
        • Simpson J.L.
        • et al.
        Cytogenetic results from the U.S. Collaborative study on CVS.
        Prenat Diagn. 1992; 12: 317-345
        • Stetten G.
        • Escallon C.S.
        • South S.T.
        • McMichael J.L.
        • Saul D.O.
        • Blakemore K.J.
        Reevaluating confined placental mosaicism.
        Am J Med Genet A. 2004; 131: 232-239
        • Lund I.C.B.
        • Becher N.
        • Christensen R.
        • et al.
        Prevalence of mosaicism in uncultured chorionic villus samples after chromosomal microarray and clinical outcome in pregnancies affected by confined placental mosaicism.
        Prenat Diagn. 2020; 40: 244-259
        • Lestou V.S.
        • Kalousek D.K.
        Confined placental mosaicism and intrauterine fetal growth.
        Arch Dis Child Fetal Neonatal Ed. 1998; 79: F223-F226
        • Robinson W.P.
        • Barrett I.J.
        • Bernard L.
        • et al.
        Meiotic origin of trisomy in confined placental mosaicism is correlated with presence of fetal uniparental disomy, high levels of trisomy in trophoblast, and increased risk of fetal intrauterine growth restriction.
        Am J Hum Genet. 1997; 60: 917-927
        • Van Opstal D.
        • Van den Berg C.
        • Deelen W.H.
        • et al.
        Prospective prenatal investigations on potential uniparental disomy in cases of confined placental trisomy.
        Prenat Diagn. 1998; 18: 35-44
        • Grati F.R.
        • Grimi B.
        • Frascoli G.
        • et al.
        Confirmation of mosaicism and uniparental disomy in amniocytes, after detection of mosaic chromosome abnormalities in chorionic villi.
        Eur J Hum Genet. 2006; 14: 282-288
        • Kalousek D.K.
        Pathogenesis of chromosomal mosaicism and its effect on early human development.
        Am J Med Genet. 2000; 91: 39-45
        • Eggenhuizen G.M.
        • Go A.
        • Koster M.P.H.
        • Baart E.B.
        • Galjaard R.J.
        Confined placental mosaicism and the association with pregnancy outcome and fetal growth: a review of the literature.
        Hum Reprod Update. 2021; 27: 885-903
        • Roland B.
        • Lynch L.
        • Berkowitz G.
        • Zinberg R.
        Confined placental mosaicism in CVS and pregnancy outcome.
        Prenat Diagn. 1994; 14: 589-593
        • Johnson A.
        • Wapner R.J.
        • Davis G.H.
        • Jackson L.G.
        Mosaicism in chorionic villus sampling: an association with poor perinatal outcome.
        Obstet Gynecol. 1990; 75: 573-577
        • Wapner R.J.
        • Simpson J.L.
        • Golbus M.S.
        • et al.
        Chorionic mosaicism: association with fetal loss but not with adverse perinatal outcome.
        Prenat Diagn. 1992; 12: 347-355
        • Toutain J.
        • Goutte-Gattat D.
        • Horovitz J.
        • Saura R.
        Confined placental mosaicism revisited: impact on pregnancy characteristics and outcome.
        PLoS One. 2018; 13e0195905
        • Toutain J.
        • Labeau-Gaüzere C.
        • Barnetche T.
        • Horovitz J.
        • Saura R.
        Confined placental mosaicism and pregnancy outcome: a distinction needs to be made between types 2 and 3.
        Prenat Diagn. 2010; 30: 1155-1164
        • Wolstenholme J.
        • Rooney D.E.
        • Davison E.V.
        Confined placental mosaicism, IUGR, and adverse pregnancy outcome: a controlled retrospective U.K. collaborative survey.
        Prenat Diagn. 1994; 14: 345-361
        • Leschot N.J.
        • Wolf H.
        • Van Prooijen-Knegt A.C.
        • et al.
        Cytogenetic findings in 1250 chorionic villus samples obtained in the first trimester with clinical follow-up of the first 1000 pregnancies.
        Br J Obstet Gynaecol. 1989; 96: 663-670
        • Amor D.J.
        • Neo W.T.
        • Waters E.
        • Heussler H.
        • Pertile M.
        • Halliday J.
        Health and developmental outcome of children following prenatal diagnosis of confined placental mosaicism.
        Prenat Diagn. 2006; 26: 443-448
        • Baffero G.M.
        • Somigliana E.
        • Crovetto F.
        • et al.
        Confined placental mosaicism at chorionic villous sampling: risk factors and pregnancy outcome.
        Prenat Diagn. 2012; 32: 1102-1108
        • Grati F.R.
        • Ferreira J.
        • Benn P.
        • et al.
        Outcomes in pregnancies with a confined placental mosaicism and implications for prenatal screening using cell-free DNA.
        Genet Med. 2020; 22: 309-316
        • Dorfmann A.D.
        • Perszyk J.
        • Robinson P.
        • Black S.H.
        • Schulman J.D.
        Rare non-mosaic trisomies in chorionic villus tissue not confirmed at amniocentesis.
        Prenat Diagn. 1992; 12: 899-902
        • Kennerknecht I.
        • Krämer S.
        • Grab D.
        • Terinde R.
        • Vogel W.
        A prospective cytogenetic study of third-trimester placentae in small-for-date but otherwise normal newborns.
        Prenat Diagn. 1993; 13: 257-269
        • Yong P.J.
        • Barrett I.J.
        • Kalousek D.K.
        • Robinson W.P.
        Clinical aspects, prenatal diagnosis, and pathogenesis of trisomy 16 mosaicism.
        J Med Genet. 2003; 40: 175-182
        • Sparks T.N.
        • Thao K.
        • Norton M.E.
        Mosaic trisomy 16: what are the obstetric and long-term childhood outcomes?.
        Genet Med. 2017; 19: 1164-1170
        • Di Renzo G.C.
        • Bartha J.L.
        • Bilardo C.M.
        Expanding the indications for cell-free DNA in the maternal circulation: clinical considerations and implications.
        Am J Obstet Gynecol. 2019; 220: 537-542
        • Eckmann-Scholz C.
        • Mallek J.
        • von Kaisenberg C.S.
        • et al.
        Chromosomal mosaicisms in prenatal diagnosis: correlation with first trimester screening and clinical outcome.
        J Perinat Med. 2012; 40: 215-223
        • Thomsen S.H.
        • Lund I.C.B.
        • Fagerberg C.
        • Bache I.
        • Becher N.
        • Vogel I.
        Trisomy 8 mosaicism in the placenta: a Danish cohort study of 37 cases and a literature review.
        Prenat Diagn. 2021; 41: 409-421
        • Sifakis S.
        • Staboulidou I.
        • Maiz N.
        • Velissariou V.
        • Nicolaides K.H.
        Outcome of pregnancies with trisomy 2 cells in chorionic villi.
        Prenat Diagn. 2010; 30: 329-332
        • Page M.J.
        • McKenzie J.E.
        • Bossuyt P.M.
        • et al.
        The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
        BMJ. 2021; 372: n71
        • Stroup D.F.
        • Berlin J.A.
        • Morton S.C.
        • et al.
        Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.
        JAMA. 2000; 283: 2008-2012
        • World Health Organization, Centers for Disease Control and Prevention
        Birth defects surveillance: quick reference handbook.
        (Available at:) (Accessed January 15, 2022)
        • Royal College of Obstetricians and Gynecologists
        Late intrauterine fetal death and stillbirth (Green-top guideline No. 55).
        2010 (Available at:) (Accesssed January 15, 2022)
        • Wells G.A.
        • Shea B.
        • O’Connell D.
        • et al.
        The Newcastle-Ottawa Scale (NOS) for assessing the quality of non randomized studies in meta-analyses.
        2010 (Available at:) (Accessed January 15, 2022)
        • Higgins J.P.T.
        • Thomas J.
        • Chandler J.
        • et al.
        Cochrane handbook for systematic reviews of interventions.
        2nd Edition. John Wiley & Sons, Chichester, United Kingdom2019
        • Higgins J.P.
        • Thompson S.G.
        • Deeks J.J.
        • Altman D.G.
        Measuring inconsistency in meta-analyses.
        BMJ. 2003; 327: 557-560
        • Grau Madsen S.
        • Uldbjerg N.
        • Sunde L.
        • Becher N.
        Danish Fetal Medicine Study Group, Danish Clinical Genetics Study Group. Prognosis for pregnancies with trisomy 16 confined to the placenta: a Danish cohort study.
        Prenat Diagn. 2018; 38: 1103-1110
        • Langlois S.
        • Yong P.J.
        • Yong S.L.
        • et al.
        Postnatal follow-up of prenatally diagnosed trisomy 16 mosaicism.
        Prenat Diagn. 2006; 26: 548-558
        • Del Gobbo G.F.
        • Yuan V.
        • Robinson W.P.
        Confined placental mosaicism involving multiple de novo copy number variants associated with fetal growth restriction: a case report.
        Am J Med Genet A. 2021; 185: 1908-1912
        • Kalousek D.K.
        Current topic: confined placental mosaicism and intrauterine fetal development.
        Placenta. 1994; 15: 219-230
        • Salomon L.J.
        • Alfirevic Z.
        • Berghella V.
        • et al.
        Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan.
        Ultrasound Obstet Gynecol. 2011; 37: 116-126
        • Rana S.
        • Lemoine E.
        • Granger J.P.
        • Karumanchi S.A.
        Preeclampsia: pathophysiology, challenges, and perspectives.
        Circ Res. 2019; 124: 1094-1112
        • Brosens I.
        • Pijnenborg R.
        • Vercruysse L.
        • Romero R.
        The “Great Obstetrical Syndromes” are associated with disorders of deep placentation.
        Am J Obstet Gynecol. 2011; 204: 193-201
        • Nicolaides K.H.
        • Papastefanou I.
        • Syngelaki A.
        • Ashoor G.
        • Akolekar R.
        Predictive performance for placental dysfunction related stillbirth of the competing risks model for small-for-gestational-age fetuses.
        BJOG. 2022; 129: 1530-1537
        • Papastefanou I.
        • Nowacka U.
        • Syngelaki A.
        • et al.
        Competing risks model for prediction of small-for-gestational-age neonates from biophysical markers at 19 to 24 weeks’ gestation.
        Am J Obstet Gynecol. 2021; 225: 530.e1-530.e19
        • Flori E.
        • Girodon E.
        • Samama B.
        • et al.
        Trisomy 7 mosaicism, maternal uniparental heterodisomy 7 and Hirschsprung’s disease in a child with Silver-Russell syndrome.
        Eur J Hum Genet. 2005; 13: 1013-1018
        • Petit F.
        • Holder-Espinasse M.
        • Duban-Bedu B.
        • et al.
        Trisomy 7 mosaicism prenatally misdiagnosed and maternal uniparental disomy in a child with pigmentary mosaicism and Russell- Silver syndrome.
        Clin Genet. 2012; 81: 265-271
        • Delatycki M.B.
        • Pertile M.D.
        • Gardner R.J.
        Trisomy 13 mosaicism at prenatal diagnosis: dilemmas in interpretation.
        Prenat Diagn. 1998; 18: 45-50
        • Redaelli S.
        • Sala E.
        • Roncaglia N.
        • et al.
        Severe intrauterine growth restriction and trisomy 15 confined placental mosaicism: a case report and review of literature.
        Prenat Diagn. 2005; 25: 140-147
      1. Trisomy 15 CPM: probable origins, pregnancy outcome and risk of fetal UPD: European Collaborative Research on Mosaicism in CVS (EUCROMIC).
        Prenat Diagn. 1999; 19: 29-35
        • Silva M.
        • Alves C.
        • Pedro S.
        • et al.
        Trisomy 15 mosaicism: challenges in prenatal diagnosis.
        Am J Med Genet A. 2015; 167A: 2847-2850
        • Papavassiliou P.
        • Charalsawadi C.
        • Rafferty K.
        • Jackson-Cook C.
        Mosaicism for trisomy 21: review.
        Am J Med Genet A. 2015; 167A: 26-39
        • Mazza V.
        • Latella S.
        • Fenu V.
        • et al.
        Prenatal diagnosis and postnatal follow-up of a child with mosaic trisomy 22 with several levels of mosaicism in different tissues.
        J Obstet Gynaecol Res. 2010; 36: 1116-1120
        • Benn P.
        • Malvestiti F.
        • Grimi B.
        • Maggi F.
        • Simoni G.
        • Grati F.R.
        Rare autosomal trisomies: comparison of detection through cell-free DNA analysis and direct chromosome preparation of chorionic villus samples.
        Ultrasound Obstet Gynecol. 2019; 54: 458-467
        • Zhen L.
        • Pan M.
        • Li D.Z.
        Pregnancies with trisomy 2 cells in chorionic villi: ultrasound determines the outcome.
        Eur J Obstet Gynecol Reprod Biol. 2021; 261: 247-248
        • Cassina M.
        • Calò A.
        • Salviati L.
        • Alghisi A.
        • Montaldi A.
        • Clementi M.
        Prenatal detection of trisomy 8 mosaicism: pregnancy outcome and follow up of a series of 17 consecutive cases.
        Eur J Obstet Gynecol Reprod Biol. 2018; 221: 23-27
        • de Wergifosse S.
        • Bevilacqua E.
        • Mezela I.
        • et al.
        Cell-free DNA analysis in maternal blood: comparing genome-wide versus targeted approach as a first-line screening test.
        J Matern Fetal Neonatal Med. 2021; 34: 3552-3561
        • Van Opstal D.
        • Eggenhuizen G.M.
        • Joosten M.
        • et al.
        Noninvasive prenatal testing as compared to chorionic villus sampling is more sensitive for the detection of confined placental mosaicism involving the cytotrophoblast.
        Prenat Diagn. 2020; 40: 1338-1342
        • Benn P.
        • Borrell A.
        • Chiu R.W.
        • et al.
        Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis.
        Prenat Diagn. 2015; 35: 725-734
        • Gregg A.R.
        • Skotko B.G.
        • Benkendorf J.L.
        • et al.
        Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics.
        Genet Med. 2016; 18: 1056-1065
        • Society for Maternal-Fetal Medicine (SMFM) Publications Committee
        Electronic address: [email protected] #36: prenatal aneuploidy screening using cell-free DNA.
        Am J Obstet Gynecol. 2015; 212: 711-716
        • Vogel I.
        • Vestergaard E.M.
        • Lildballe D.L.
        • et al.
        Placental mosaicism in the era of chromosomal microarrays.
        Eur J Med Genet. 2020; 63103778
        • Popovic M.
        • Dhaenens L.
        • Boel A.
        • Menten B.
        • Heindryckx B.
        Erratum. Chromosomal mosaicism in human blastocysts: the ultimate diagnostic dilemma.
        Hum Reprod Update. 2020; 26: 450-451
      2. International Society for Prenatal Diagnosis, Society for Maternal and Fetal Medicine, Perinatal Quality Foundation. Joint Position Statement from the International Society for Prenatal Diagnosis (ISPD), the Society for Maternal Fetal Medicine (SMFM), and the Perinatal Quality Foundation (PQF) on the use of genome-wide sequencing for fetal diagnosis.
        Prenat Diagn. 2018; 38: 6-9